Key protein that may cause cancer cell death identified

January 16, 2009,

Researchers at A*STAR's Institute of Molecular and Cell Biology (IMCB) have become the first to discover and characterize a human protein called Bax-beta (Baxβ), which can potentially cause the death of cancer cells and lead to new approaches in cancer treatment. The finding is published in the 16 Jan. report of Molecular Cell.

Detection of Baxβ has eluded scientists until now. Said Dr Victor Yu, principal investigator of the IMCB research team, "Our research findings reveal that Baxβ protein levels are normally kept at essentially undetectable levels in healthy cells by the protein degradation machine in cells known as proteasomes.

Proteasomes are "protein-digesting machines" that regulate cellular levels of various proteins including that of the lethal Baxβ, by breaking them into smaller components within the cell.

"Thus, the proteasomes are there to keep the lethal Baxβ in check," he added. "This is exciting — if the proteasome-mediated degradation of Baxβ could be inhibited specifically in cancer cells, it could cause the harmful cancer cells to go through apoptosis". In apoptosis, unwanted, damaged and infected cells are eliminated.

Until the discovery of Baxβ by Dr. Yu's team, only one single protein called Bax-alpha (Baxα) had been extensively studied in cells. Earlier evidence had suggested that more than one protein was encoded by the Bax gene.

However, only a single protein called Baxα had ever been detected and extensively studied in cells. Bax is known to be a key gene needed for the execution step of apoptosis, or programmed cell death.

The researchers also found that Baxβ is able to associate with, and promote, Baxα activation, and that Baxβ, in its native form, is 100 times more potent than its sibling Baxα in triggering a key step in apoptosis.

The future development of novel compounds that can selectively elevate levels of Baxβ or stimulate its interaction with Baxα could also lead to new drug approaches to cancer treatment, as these compounds are likely to enhance the apoptotic signals triggered by many conventional cancer drugs, which frequently cause toxic side effects in patients when higher doses of drugs are needed.

Dr. David Andrews, Professor of Biochemistry and Biomedical Sciences at McMaster University, Canada added, "The beta-isoform4 of Bax has been enigmatic for several years. Although earlier research had hinted at its existence, the protein has proven extremely difficult to detect or examine functionally. Even attempts to produce the protein in the laboratory have been largely unsuccessful. In this study the Yu group resolves these issues by demonstrating that in cells Baxβ is normally rapidly degraded and kept at low levels, and when it is not degraded, it is profoundly apoptotic on its own and works in concert with Baxα. These studies provide information necessary for the elucidation of the importance of Baxβ in cell physiology."

The research findings are reported in the article, "Baxβ: A Constitutively Active Human Bax Isoform that is under Tight Regulatory Control by the Proteasomal Degradation Mechanism," in the Jan. 16, 2009 print issue of Molecular Cell.

Source: Agency for Science, Technology and Research (A*STAR), Singapore

Explore further: Fast-tracking T cell therapies with immune-mimicking biomaterials

Related Stories

Research reveals atomic-level changes in ALS-linked protein

January 18, 2018

For the first time, researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases ...

Recommended for you

Cells lacking nuclei struggle to move in 3-D environments

January 20, 2018

University of North Carolina Lineberger Comprehensive Cancer Center researchers have revealed new details of how the physical properties of the nucleus influence how cells can move around different environments - such as ...

Information engine operates with nearly perfect efficiency

January 19, 2018

Physicists have experimentally demonstrated an information engine—a device that converts information into work—with an efficiency that exceeds the conventional second law of thermodynamics. Instead, the engine's efficiency ...

Team takes a deep look at memristors

January 19, 2018

In the race to build a computer that mimics the massive computational power of the human brain, researchers are increasingly turning to memristors, which can vary their electrical resistance based on the memory of past activity. ...

Fast computer control for molecular machines

January 19, 2018

Scientists at the Technical University of Munich (TUM) have developed a novel electric propulsion technology for nanorobots. It allows molecular machines to move a hundred thousand times faster than with the biochemical processes ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

E_L_Earnhardt
not rated yet Jan 16, 2009
Please get over the drive to "kill the cell"! Cyroablation will do that without making paupers out of patients. Long before you freeze it reduced temp. will calm the radicals and the cell will again function properly!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.